Toumaz plans FDA submission in 2011

By Brian Dolan
02:00 am
Share

Toumaz Sensium Life PebbleToumaz, a wireless medical sensor company based in the United Kingdom, told investors that it has made operational strides for both healthcare industry products and consumer-focused initiatives. While Toumaz launched its CE marked Life Pebble late last year, it has plans to submit an end-to-end wireless vital signs monitoring system for FDA clearance and a CE mark later next year.

Toumaz said its first trials with St. Mary's Hospital and Carefusion completed earlier this year. A new set of trials will begin in the fourth quarter of 2010. The company also expects to collect its first licensing royalties from customers by the end of the year.

The company's Sensium Life Pebble monitoring system is now available in the European Union and other countries that have adopted the CE standard for certified medical devices, according to an announcement the company made late last year. The Life Pebble includes a single lead ECG, skin thermometer, and an accelerometer, which enables it to track physical activity. The device works for up to five days on a single hearing aid-sized batter, according to the company. The data collected by the system is intended for use by clinicians for analysis, according to the company’s press release. The Life Pebble streams data over a short range wireless link to a Sensium USB Network Adapter.

For more on Toumaz check out this report from RTT News

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!